Functional reconstitution of human neuropeptide Y (NPY) Y₂ and Y₄ receptors in Sf9 insect cells

References

• Merten N, Beck-Sickinger AG. Molecular ligand-receptor interaction of the NPY/PP peptide family. EXS 2006, 35–62.
   Google Scholar
• Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 1998, 50, 143–150.
   PubMed Web of Science ®Google Scholar
• Gehlert DR. Neuropeptide Y (NP Y) and its receptors. In: Squire LR, editor. Encyclopedia of Neuroscience 2009. La Jolla, CA: Academic Press, 2009, pp. 837–842.
   Google Scholar
• Pedrazzini T, Pralong F, Grouzmann E. Neuropeptide Y: the universal soldier. Cell Mol Life Sci 2003, 60, 350–377.
   PubMed Web of Science ®Google Scholar
• Henry M, Ghibaudi L, Gao J, Hwa JJ. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors. Obes Res 2005, 13, 36–47.
   PubMedGoogle Scholar
• Mullins D, Kirby D, Hwa J, Guzzi M, Rivier J, Parker E. Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo. Mol Pharmacol 2001, 60, 534–540.
   PubMed Web of Science ®Google Scholar
• Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996, 382, 168–171.
   PubMed Web of Science ®Google Scholar
• Mashiko S, Ishihara A, Iwaasa H, Sano H, Oda Z, Ito J, Yumoto M, Okawa M, Suzuki J, Fukuroda T, Jitsuoka M, Morin NR, MacNeil DJ, Van der Ploeg LH, Ihara M, Fukami T, Kanatani A. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY. Endocrinology 2003, 144, 1793–1801.
   PubMed Web of Science ®Google Scholar
• Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418, 650–654.
   PubMed Web of Science ®Google Scholar
• Asakawa A, Inui A, Yuzuriha H, Ueno N, Katsuura G, Fujimiya M, Fujino MA, Niijima A, Meguid MM, Kasuga M. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 2003, 124, 1325–1336.
   PubMed Web of Science ®Google Scholar
• Sato N, Ogino Y, Mashiko S, Ando M. Modulation of neuropeptide Y receptors for the treatment of obesity. Expert Opin Ther Pat 2009, 19, 1401–1415.
   PubMed Web of Science ®Google Scholar
• Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost HG, Klaus S, Thöne-Reineke C, Benoit SC, Seeley RJ, Beck-Sickinger AG, Koglin N, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Ortmann S, Castañeda TR, Tschöp M. PYY3-36 as an anti-obesity drug target. Obes Rev 2005, 6, 307–322.
   Google Scholar
• Brothers SP, Saldanha SA, Spicer TP, Cameron M, Mercer BA, Chase P, McDonald P, Wahlestedt C, Hodder PS. Selective and brain penetrant neuropeptide Y Y2 receptor antagonists discovered by whole-cell high-throughput screening. Mol Pharmacol 2010, 77, 46–57.
   PubMed Web of Science ®Google Scholar
• Shoblock JR, Welty N, Nepomuceno D, Lord B, Aluisio L, Fraser I, Motley ST, Sutton SW, Morton K, Galici R, Atack JR, Dvorak L, Swanson DM, Carruthers NI, Dvorak C, Lovenberg TW, Bonaventure P. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor. Psychopharmacology (Berl) 2010, 208, 265–277.
   Google Scholar
• Ziemek R, Schneider E, Kraus A, Cabrele C, Beck-Sickinger AG, Bernhardt G, Buschauer A. Determination of affinity and activity of ligands at the human neuropeptide Y Y4 receptor by flow cytometry and aequorin luminescence. J Recept Signal Transduct Res 2007, 27, 217–233.
   Web of Science ®Google Scholar
• Bischoff A, Püttmann K, Kötting A, Moser C, Buschauer A, Michel MC. Limited signal transduction repertoire of human Y(5) neuropeptide Y receptors expressed in HEC-1B cells. Peptides 2001, 22, 387–394.
   PubMedGoogle Scholar
• Dautzenberg FM, Higelin J, Pflieger P, Neidhart W, Guba W. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist. Neuropharmacology 2005, 48, 1043–1055.
   Google Scholar
• Gerald C, Walker MW, Vaysse PJ, He C, Branchek TA, Weinshank RL. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J Biol Chem 1995, 270, 26758–26761.
   PubMed Web of Science ®Google Scholar
• Lundell I, Blomqvist AG, Berglund MM, Schober DA, Johnson D, Statnick MA, Gadski RA, Gehlert DR, Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 1995, 270, 29123–29128.
   PubMed Web of Science ®Google Scholar
• Parker EM, Babij CK, Balasubramaniam A, Burrier RE, Guzzi M, Hamud F, Mukhopadhyay G, Rudinski MS, Tao Z, Tice M, Xia L, Mullins DE, Salisbury BG. GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur J Pharmacol 1998, 349, 97–105.
   PubMedGoogle Scholar
• Dumont Y, Cadieux A, Doods H, Pheng LH, Abounader R, Hamel E, Jacques D, Regoli D, Quirion R. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol 2000, 129, 1075–1088.
   Google Scholar
• Merten N, Lindner D, Rabe N, Römpler H, Mörl K, Schöneberg T, Beck-Sickinger AG. Receptor subtype-specific docking of Asp6.59 with C-terminal arginine residues in Y receptor ligands. J Biol Chem 2007, 282, 7543–7551.
   Google Scholar
• Berridge MJ. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J 1983, 212, 849–858.
   PubMed Web of Science ®Google Scholar
• Ziemek R, Brennauer A, Schneider E, Cabrele C, Beck-Sickinger AG, Bernhardt G, Buschauer A. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands. Eur J Pharmacol 2006, 551, 10–18.
   Google Scholar
• Schneider EH, Seifert R. Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors. Pharmacol Ther 2010, 128, 387–418.
   PubMed Web of Science ®Google Scholar
• Wieland T, Seifert R. Methodological approaches. In: Seifert R, Wieland T, editors. G-Protein Coupled Receptors as Drug Targets (Methods and Principles in Medicinal Chemistry). Weinheim, Germany: Wiley-VCH, 2005, pp. 81–120.
   Google Scholar
• Massotte D. G protein-coupled receptor overexpression with the baculovirus-insect cell system: a tool for structural and functional studies. Biochim Biophys Acta 2003, 1610, 77–89.
   Google Scholar
• Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007, 450, 383–387.
   PubMed Web of Science ®Google Scholar
• Quehenberger O, Prossnitz ER, Cochrane CG, Ye RD. Absence of G(i) proteins in the Sf9 insect cell. Characterization of the uncoupled recombinant N-formyl peptide receptor. J Biol Chem 1992, 267, 19757–19760.
   PubMedGoogle Scholar
• Mulheron JG, Casañas SJ, Arthur JM, Garnovskaya MN, Gettys TW, Raymond JR. Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s). J Biol Chem 1994, 269, 12954–12962.
   Google Scholar
• Parker EM, Kameyama K, Higashijima T, Ross EM. Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J Biol Chem 1991, 266, 519–527.
   PubMed Web of Science ®Google Scholar
• Munoz M, Sautel M, Martinez R, Sheikh SP, Walker P. Characterization of the human Y1 neuropeptide Y receptor expressed in insect cells. Mol Cell Endocrinol 1995, 107, 77–86.
   Google Scholar
• Kakui N, Tanaka J, Tabata Y, Asai K, Masuda N, Miyara T, Nakatani Y, Ohsawa F, Nishikawa N, Sugai M, Suzuki M, Aoki K, Kitaguchi H. Pharmacological characterization and feeding-suppressive property of FMS586 [3-(5,6,7,8-tetrahydro-9-isopropyl-carbazol-3-yl)-1-methyl-1-(2-pyridin-4-yl-ethyl)-urea hydrochloride], a novel, selective, and orally active antagonist for neuropeptide Y Y5 receptor. J Pharmacol Exp Ther 2006, 317, 562–570.
   PubMed Web of Science ®Google Scholar
• Block MH, Boyer S, Brailsford W, Brittain DR, Carroll D, Chapman S, Clarke DS, Donald CS, Foote KM, Godfrey L, Ladner A, Marsham PR, Masters DJ, Mee CD, O’Donovan MR, Pease JE, Pickup AG, Rayner JW, Roberts A, Schofield P, Suleman A, Turnbull AV. Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity. J Med Chem 2002, 45, 3509–3523.
   PubMed Web of Science ®Google Scholar
• Daniels AJ, Matthews JE, Slepetis RJ, Jansen M, Viveros OH, Tadepalli A, Harrington W, Heyer D, Landavazo A, Leban JJ, Spaltenstein A. High-affinity neuropeptide Y receptor antagonists. Proc Natl Acad Sci USA 1995, 92, 9067–9071.
   PubMed Web of Science ®Google Scholar
• Cabrele C, Wieland HA, Langer M, Stidsen CE, Beck-Sickinger AG. Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity. Peptides 2001, 22, 365–378.
   Google Scholar
• Doods H, Gaida W, Wieland HA, Dollinger H, Schnorrenberg G, Esser F, Engel W, Eberlein W, Rudolf K. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol 1999, 384, R3–R5.
   Google Scholar
• Dollinger H, Esser F, Mihm G, Rudolf K, Schnorrenberg G, Gaida W, Doods HN, inventors; Boehringer Ingelheim Pharma, assignee. Preparation of novel peptides for use as NPY antagonists. Ger Offen patent DE 19816929, 1999.
   Google Scholar
• Brennauer A. Acylguanidines as bioisosteric groups in argininamide-type neuropeptide Y Y1 and Y2 receptor antagonists: synthesis, stability and pharmacological activity [Thesis]. Regensburg, Germany: University of Regensburg, 2006.
   Google Scholar
• Walseth TF, Johnson RA. The enzymatic preparation of [alpha-(32)P]nucleoside triphosphates, cyclic [32P] AMP, and cyclic [32P] GMP. Biochim Biophys Acta 1979, 562, 11–31.
   PubMedGoogle Scholar
• Seifert R, Lee TW, Lam VT, Kobilka BK. Reconstitution of beta2-adrenoceptor-GTP-binding-protein interaction in Sf9 cells–high coupling efficiency in a beta2-adrenoceptor-G(s alpha) fusion protein. Eur J Biochem 1998, 255, 369–382.
   Google Scholar
• Wenzel-Seifert K, Seifert R. Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor. Biochem Biophys Res Commun 2003, 301, 693–698.
   Google Scholar
• Kleemann P, Papa D, Vigil-Cruz S, Seifert R. Functional reconstitution of the human chemokine receptor CXCR4 with G(i)/G(o)-proteins in Sf9 insect cells. Naunyn Schmiedebergs Arch Pharmacol 2008, 378, 261–274.
   Google Scholar
• Preuss H, Ghorai P, Kraus A, Dove S, Buschauer A, Seifert R. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors. J Pharmacol Exp Ther 2007, 321, 983–995.
   Google Scholar
• Cheng Y, Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973, 22, 3099–3108.
   PubMed Web of Science ®Google Scholar
• Bard JA, Walker MW, Branchek TA, Weinshank RL. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 1995, 270, 26762–26765.
   PubMed Web of Science ®Google Scholar
• Wimalawansa SJ. Purification and biochemical characterization of neuropeptide Y2 receptor. J Biol Chem 1995, 270, 18523–18530.
   Google Scholar
• Voisin T, Goumain M, Lorinet AM, Maoret JJ, Laburthe M. Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization. J Pharmacol Exp Ther 2000, 292, 638–646.
   Google Scholar
• Fabre C, el Battari A, Karamanos Y, Couvineau A, Salomon R, Laburthe M, Marvaldi J, Pichon J, Luis J. Glycosylation of VIP receptors: a molecular basis for receptor heterogeneity. Peptides 1993, 14, 483–489.
   PubMedGoogle Scholar
• Grünewald S, Haase W, Reiländer H, Michel H. Glycosylation, palmitoylation, and localization of the human D2S receptor in baculovirus-infected insect cells. Biochemistry 1996, 35, 15149–15161.
   Google Scholar
• Seifert R, Wenzel-Seifert K. Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis. J Biol Chem 2001, 276, 42043–42049.
   PubMedGoogle Scholar
• Seifert R, Wenzel-Seifert K, Burckstummer T, Pertz HH, Schunack W, Dove S, Buschauer A, Elz S. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor. J Pharmacol Exp Ther 2003, 305, 1104–1115.
   PubMed Web of Science ®Google Scholar
• Sternweis PC, Robishaw JD. Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem 1984, 259, 13806–13813.
   PubMed Web of Science ®Google Scholar
• Seifert R, Wenzel-Seifert K. Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state. Recept Channels 2001, 7, 357–369.
   Google Scholar
• Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 2002, 366, 381–416.
   PubMed Web of Science ®Google Scholar
• Schnell D, Seifert R. Modulation of histamine H(3) receptor function by monovalent ions. Neurosci Lett 2010, 472, 114–118.
   Web of Science ®Google Scholar
• Gille A, Seifert R. Co-expression of the beta2-adrenoceptor and dopamine D1-receptor with Gs alpha proteins in Sf9 insect cells: limitations in comparison with fusion proteins. Biochim Biophys Acta 2003, 1613, 101–114.
   Google Scholar
• Schnell D, Burleigh K, Trick J, Seifert R. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers. J Pharmacol Exp Ther 2010, 332, 996–1005.
   Google Scholar
• Dautzenberg FM. Stimulation of neuropeptide Y-mediated calcium responses in human SMS-KAN neuroblastoma cells endogenously expressing Y2 receptors by co-expression of chimeric G proteins. Biochem Pharmacol 2005, 69, 1493–1499.
   Google Scholar
• Walker MW, Smith KE, Bard J, Vaysse PJ, Gerald C, Daouti S, Weinshank RL, Branchek TA. A structure–activity analysis of the cloned rat and human Y4 receptors for pancreatic polypeptide. Peptides 1997, 18, 609–612.
   Google Scholar
• Cox HM, Tough IR, Zandvliet DW, Holliday ND. Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines. Br J Pharmacol 2001, 132, 345–353.
   Google Scholar
• Ziemek R. Development of binding and functional assays for the neuropeptide Y Y2 and Y4 receptor [Thesis]. Regensburg, Germany: University of Regensburg, 2006.
   Google Scholar
• Schneider EH, Schnell D, Papa D, Seifert R. High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor. Biochemistry 2009, 48, 1424–1438.
   Google Scholar
• Kelley LP, Kinsella BT. The role of N-linked glycosylation in determining the surface expression, G protein interaction and effector coupling of the alpha (alpha) isoform of the human thromboxane A(2) receptor. Biochim Biophys Acta 2003, 1621, 192–203.
   Google Scholar
• Zhou H, Tai HH. Characterization of recombinant human CXCR4 in insect cells: role of extracellular domains and N-glycosylation in ligand binding. Arch Biochem Biophys 1999, 369, 267–276.
   Google Scholar
• Yurugi-Kobayashi T, Asada H, Shiroishi M, Shimamura T, Funamoto S, Katsuta N, Ito K, Sugawara T, Tokuda N, Tsujimoto H, Murata T, Nomura N, Haga K, Haga T, Iwata S, Kobayashi T. Comparison of functional non-glycosylated GPCRs expression in Pichia pastoris. Biochem Biophys Res Commun 2009, 380, 271–276.
   Google Scholar
• Misra S, Murthy KS, Zhou H, Grider JR. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways. J Pharmacol Exp Ther 2004, 311, 1154–1162.
   Google Scholar
• Birnbaumer L, Abramowitz J, Brown AM. Receptor–effector coupling by G proteins. Biochim Biophys Acta 1990, 1031, 163–224.
   PubMed Web of Science ®Google Scholar
• Schneider EH, Seifert R. Histamine H(4) receptor–RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands. Biochem Pharmacol 2009, 78, 607–616.
   Google Scholar
• Chen G, Way J, Armour S, Watson C, Queen K, Jayawickreme CK, Chen WJ, Kenakin T. Use of constitutive G protein-coupled receptor activity for drug discovery. Mol Pharmacol 2000, 57, 125–134.
   PubMed Web of Science ®Google Scholar
• Wenzel-Seifert K, Hurt CM, Seifert R. High constitutive activity of the human formyl peptide receptor. J Biol Chem 1998, 273, 24181–24189.
   PubMed Web of Science ®Google Scholar
• Parker MS, Lundell I, Parker SL. Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding. Peptides 2002, 23, 291–303.
   Google Scholar
• Higashijima T, Ferguson KM, Sternweis PC. Regulation of hormone-sensitive GTP-dependent regulatory proteins by chloride. J Biol Chem 1987, 262, 3597–3602.
   Google Scholar
• Seifert R. Monovalent anions differentially modulate coupling of the beta2-adrenoceptor to G(s)alpha splice variants. J Pharmacol Exp Ther 2001, 298, 840–847.
   PubMed Web of Science ®Google Scholar
• Lindner D, Stichel J, Beck-Sickinger AG. Molecular recognition of the NPY hormone family by their receptors. Nutrition 2008, 24, 907–917.
   PubMed Web of Science ®Google Scholar
• Berglund MM, Schober DA, Statnick MA, McDonald PH, Gehlert DR. The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced beta-arrestin 2 interaction. J Pharmacol Exp Ther 2003, 306, 147–156.
   Google Scholar
• Berglund MM, Schober DA, Esterman MA, Gehlert DR. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J Pharmacol Exp Ther 2003, 307, 1120–1126.
   PubMedGoogle Scholar
• Kenakin T. Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB J 2001, 15, 598–611.
   PubMed Web of Science ®Google Scholar
• Kenakin T. Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 2007, 72, 1393–1401.
   PubMed Web of Science ®Google Scholar
• Kenakin T. Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 2011, 336, 296–302.
   PubMed Web of Science ®Google Scholar
• Neubig RR. Missing links: mechanisms of protean agonism. Mol Pharmacol 2007, 71, 1200–1202.
   Google Scholar
• Perez DM, Karnik SS. Multiple signaling states of G-protein-coupled receptors. Pharmacol Rev 2005, 57, 147–161.
   PubMed Web of Science ®Google Scholar
• Luttrell LM, Gesty-Palmer D. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 2010, 62, 305–330.
   PubMed Web of Science ®Google Scholar
• Parker SL, Kane JK, Parker MS, Berglund MM, Lundell IA, Li MD. Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. Eur J Biochem 2001, 268, 877–886.
   Google Scholar
• Böhme I, Stichel J, Walther C, Mörl K, Beck-Sickinger AG. Agonist induced receptor internalization of neuropeptide Y receptor subtypes depends on third intracellular loop and C-terminus. Cell Signal 2008, 20, 1740–1749.
   Google Scholar
• Jozwiak K, Khalid C, Tanga MJ, Berzetei-Gurske I, Jimenez L, Kozocas JA, Woo A, Zhu W, Xiao RP, Abernethy DR, Wainer IW. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor. J Med Chem 2007, 50, 2903–2915.
   PubMed Web of Science ®Google Scholar
• Rosethorne EM, Charlton SJ. Agonist-biased signaling at the histamine H4 receptor: JNJ7777120 recruits beta-arrestin without activating G proteins. Mol Pharmacol 2011, 79, 749–757.
   PubMedGoogle Scholar